Before we dive into some pharma's with attractive dividends, keep in mind that I never buy stocks at year-to-date (YTD) highs or that have recently had a bull run. My personal favorite is $ABBV. The amazing dividend yield, and volatility. It allows me to have the opportunity to buy in at a perceived low.
1. Cardinal Health, Inc. (NYSE: CAH)
Dividend Yield: 2.50%
Number of Hedge Fund Holders: 50
Key Points:
Pharmaceutical and medical products distributor.
36 years of consecutive dividend increases.
Strong cash flow generation and solid fundamentals.
2. AbbVie Inc. (NYSE: ABBV)
Dividend Yield: 3.80% (as of February 3, 2024)
Number of Hedge Fund Holders: 77
Key Points:
Immunology-based biopharmaceutical company with a focus on Humira, Imbruvica, Rinvoq, and other drugs.
Strong product pipeline with potential for future growth.
Consistent revenue growth and strong cash flow generation.
11 consecutive years of dividend increases.
3. Johnson & Johnson (NYSE: JNJ)
Dividend Yield: 2.62%
Number of Hedge Fund Holders: 88
Key Points:
Pharmaceutical and medical devices conglomerate.
60 years of consecutive dividend increases.
Diversified business model with strong brand recognition in pharmaceuticals and medical devices.
4. Amgen Inc. (NASDAQ: AMGN)
Dividend Yield: 3.43%
Number of Hedge Fund Holders: 60
Key Points:
Biopharmaceutical company.
Increased free cash flow in FY22.
Consistent dividend increases since 2011.
5. Gilead Sciences, Inc. (NASDAQ: GILD)
Dividend Yield: 3.59%
Number of Hedge Fund Holders: 64
Key Points:
Pharmaceutical company specializing in antiviral drugs.
Eight-year streak of dividend growth.
Positive data from recent studies boosted investor confidence.
Remember: While these stocks have attractive dividend yields, investing involves risk. Conduct your own research before making any investment decisions.
Please note: This list does not constitute financial advice, and you should always consult with a financial professional before making any investment decisions.
Comments